The contrasting results in gene expression between the IBC models could be explained by previous studies which have demonstrated that the amplification or overexpression of HER2 promotes the activation of NF-κB and STAT3 in contrast to TNBCs [55,56]. The gene discussed is ERBB2; the disease is inflammatory breast carcinoma.